12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga·10/03/2025 21:05:59

Listen to the news

Gainers

SCWorx (NASDAQ:WORX) stock rose 22.2% to $0.39 during Friday's after-market session. The market value of their outstanding shares is at $2.8 million.
SAB Biotherapeutics (NASDAQ:SABS) shares rose 17.47% to $2.42. The company's market cap stands at $18.6 million.
Galecto (NASDAQ:GLTO) shares rose 14.74% to $4.35. The company's market cap stands at $5.2 million.
Reviva Pharmaceuticals (NASDAQ:RVPH) shares increased by 6.42% to $0.58. The company's market cap stands at $46.9 million.
ProPhase Labs (NASDAQ:PRPH) shares moved upwards by 4.53% to $0.58. The company's market cap stands at $22.7 million.
ARS Pharmaceuticals (NASDAQ:SPRY) stock rose 4.46% to $10.77. The company's market cap stands at $1.0 billion.

Losers

Nasus Pharma (AMEX:NSRX) stock decreased by 11.9% to $6.0 during Friday's after-market session. The market value of their outstanding shares is at $56.5 million.
Cosmos Health (NASDAQ:COSM) shares declined by 11.07% to $0.96. The company's market cap stands at $34.4 million.
Abpro Hldgs (NASDAQ:ABP) stock decreased by 10.14% to $0.19. The market value of their outstanding shares is at $18.3 million.
Anbio Biotechnology (NASDAQ:NNNN) shares fell 5.17% to $30.5. The company's market cap stands at $1.1 billion.
Trevi Therapeutics (NASDAQ:TRVI) shares declined by 4.59% to $9.43. The company's market cap stands at $1.1 billion.
Q/C Technologies (NASDAQ:QCLS) shares fell 4.42% to $5.5. The company's market cap stands at $9.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English